

| 카탈로그 번호 | DB796018 |
|---|---|
| 설명 |
Varlilumab ELISA Kit (DB796018) — Quantitative sandwich ELISA for Varlilumab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
|
| 샘플 유형 | Plasma, Serum |
| 민감도 | 0.156 μg/ml |
| 범위 | 0.31-5 μg/mL |
| 등록번호 | P26842 |
| 응용 분야 | ELISA |
| 검출 방법 | Colorimetric |
| 분석 유형 | Quantitative |
| 회수율 | 80-120% |
| 배송 | 2-8 ℃ |
| 안정성 및 저장 | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 20% prior to the expiration date under appropriate storage condition. |
| 사양 | Varlilumab |
| 대체 이름 | 1F5, CDX-1127, 1393344-72-3 |
| 배경 | CD27 antigen (Varlilumab) is a ~29 kDa protein. Costimulatory immune-checkpoint receptor expressed at the surface of T-cells, NK-cells and B-cells which binds to and is activated by its ligand CD70/CD27L expressed by B-cells. The CD70-CD27 signaling pathway mediates antigen-specific T-cell activation and expansion which in turn provides immune surveillance of B-cells. Mechanistically, CD70 ligation activates the TRAF2-PTPN6 axis that subsequently inhibits LCK phosphorylation to promote phenotypic and transcriptional adaptations of T-cell memory. In addition, activation by CD70 on early progenitor cells provides a negative feedback signal to leukocyte differentiation during immune activation and thus modulates hematopoiesis. Negatively regulates the function of Th2 lymphocytes in the adipose tissue. 1. Izawa, K. et al. (2017) The Journal of experimental medicine 214, 73-89. PMID: 28011863 2. Jaeger-Ruckstuhl, CA. et al. (2024) Immunity 57, 287-302.e12. PMID: 38354704 |
| 참고사항 | For Research Use Only. |

Standard Curve of Varlilumab ELISA Kit






+86-027-65523339
중국 우한시 심둔사로 666번지 C동, 우한, 430206

中文
English
한국어
日本語
Español
Français
Русский